Skip to content

NeuroPace Inc

NPCE· NasdaqCore metricsCIK 1528287

Surgical & medical instruments & apparatus143 peers

Last sale
Nov 2, 2026 · +0.73%
Market cap
$425.92M
34.43M shares
Filings
355
$23.10M
Q3 2026+25.1% FY25 yoy
-$3.30M
Q3 2026N/M FY25 yoy
-$2.08M
Q3 2026N/M FY25 yoy
-$12.82M
Q3 2026derivedN/M FY25 yoy
-$0.10
Q3 2026N/M FY25 yoy
$10.24M
Q3 2026+61.5% FY25 yoy
$425.92M
—
4.2×
37.1×
-2.91%
—

Twelve months to Sep 30, 2026 · derived

Price

$12.37+31.74%+$2.98past year
Nov 2, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$99.99MFY 2025
$99.99M0FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$99,986,000reported
FY 20242024-12-31$79,906,000reported
FY 20232023-12-31$65,421,000reported
FY 20222022-12-31$45,520,000reported
FY 20212021-12-31$45,183,000reported
FY 20202020-12-31$41,138,000reported

Capital returns

Dividends and buybacks · FY2024 to FY2025
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2025—$49.55M$49.55M$0.0033.67M sh+3.4%—
FY2024—$0.00$0.00$0.0032.56M sh+14.9%—

Surgical & medical instruments & apparatus

NeuroPace Inc is the 50th largest of the 144 covered companies the SEC files under this code, by revenue. SIC 3841

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

NeuroPace Inc · CIK 1528287 · Engraved from SEC EDGAR